Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats

Diabetic cardiomyopathy, especially myocardial ischemia reperfusion (I/R) injury, is a major cause of morbidity and mortality in type 2 diabetic patients. The increasing of basal p38 MAP Kinase (p38 MAPK) activation is a major factor that aggravates cardiac death on diabetic cardiomyopathy. In addit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanit, Jantira, Prompunt, Eakkapote, Adulyaritthikul, Punyanuch, Nokkaew, Nuttikarn, Mongkolpathumrat, Podsawee, Kongpol, Kantapich, Kijtawornrat, Anusak, Petchdee, Soontaree, Barrère-Lemaire, Stephanie, Kumphune, Sarawut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676201/
https://www.ncbi.nlm.nih.gov/pubmed/31410128
http://dx.doi.org/10.3892/etm.2019.7763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676201/
https://www.ncbi.nlm.nih.gov/pubmed/31410128
http://dx.doi.org/10.3892/etm.2019.7763

Ejemplares similares